Goldman Sachs’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.92M | Sell |
854,730
-86,443
| -9% | -$269K | ﹤0.01% | 4364 |
|
|
2026
Q1 | $2.15M | Buy |
941,173
+275,048
| +41% | +$633K | ﹤0.01% | 4472 |
|
|
2025
Q4 | $1.87M | Sell |
666,125
-30,666
| -4% | -$110K | ﹤0.01% | 4652 |
|
|
2025
Q3 | $3.34M | Buy |
696,791
+337,875
| +94% | +$2.15M | ﹤0.01% | 4021 |
|
|
2025
Q2 | $3.27M | Sell |
358,916
-217,883
| -38% | -$1.61M | ﹤0.01% | 3810 |
|
|
2025
Q1 | $5.21M | Buy |
576,799
+175,866
| +44% | +$1.86M | ﹤0.01% | 3311 |
|
|
2024
Q4 | $5.24M | Buy |
400,933
+13,264
| +3% | +$177K | ﹤0.01% | 3405 |
|
|
2024
Q3 | $6.08M | Buy |
387,669
+66,544
| +21% | +$1.01M | ﹤0.01% | 3171 |
|
|
2024
Q2 | $4.34M | Buy |
321,125
+69,016
| +27% | +$1.41M | ﹤0.01% | 3288 |
|
|
2024
Q1 | $6.99M | Sell |
252,109
-69,644
| -22% | -$1.55M | ﹤0.01% | 2798 |
|
|
2023
Q4 | $6.2M | Sell |
321,753
-615,567
| -66% | -$11.1M | ﹤0.01% | 2980 |
|
|
2023
Q3 | $15.1M | Sell |
937,320
-23,592
| -2% | -$419K | ﹤0.01% | 2026 |
|
|
2023
Q2 | $18.3M | Buy |
960,912
+325,701
| +51% | +$5.81M | ﹤0.01% | 1928 |
|
|
2023
Q1 | $9.24M | Sell |
635,211
-267,405
| -30% | -$4.79M | ﹤0.01% | 2494 |
|
|
2022
Q4 | $17.6M | Sell |
902,616
-371,103
| -29% | -$7.24M | ﹤0.01% | 2079 |
|
|
2022
Q3 | $30.7M | Sell |
1,273,719
-43,439
| -3% | -$1.34M | 0.01% | 1502 |
|
|
2022
Q2 | $41.4M | Sell |
1,317,158
-75,210
| -5% | -$2.72M | 0.01% | 1255 |
|
|
2022
Q1 | $61.3M | Sell |
1,392,368
-32,509
| -2% | -$1.4M | 0.01% | 1117 |
|
|
2021
Q4 | $62M | Buy |
1,424,877
+425,537
| +43% | +$16.7M | 0.01% | 1167 |
|
|
2021
Q3 | $31.3M | Sell |
999,340
-167,938
| -14% | -$6.61M | 0.01% | 1652 |
|
|
2021
Q2 | $49.4M | Sell |
1,167,278
-14,998
| -1% | -$583K | 0.01% | 1270 |
|
|
2021
Q1 | $44.4M | Buy |
1,182,276
+158,213
| +15% | +$4.95M | 0.01% | 1262 |
|
|
2020
Q4 | $27.7M | Buy |
1,024,063
+711,769
| +228% | +$18.3M | 0.01% | 1584 |
|
|
2020
Q3 | $7.84M | Sell |
312,294
-173,743
| -36% | -$2.53M | ﹤0.01% | 2528 |
|
|
2020
Q2 | $3.7M | Sell |
486,037
-1,199,759
| -71% | -$8.78M | ﹤0.01% | 3011 |
|
|
2020
Q1 | $15.4M | Buy |
1,685,796
+1,344,185
| +393% | +$8.11M | 0.01% | 1719 |
|
|
2019
Q4 | $1.77M | Buy |
341,611
+60,142
| +21% | +$386K | ﹤0.01% | 3732 |
|
|
2019
Q3 | $1.64M | Sell |
281,469
-55,207
| -16% | -$248K | ﹤0.01% | 3675 |
|
|
2019
Q2 | $1.08M | Sell |
336,676
-371,770
| -52% | -$1.27M | ﹤0.01% | 3949 |
|
|
2019
Q1 | $2.9M | Buy |
708,446
+54,929
| +8% | +$347K | ﹤0.01% | 3357 |
|
|
2018
Q4 | $4.14M | Sell |
653,517
-512,329
| -44% | -$5.32M | ﹤0.01% | 3044 |
|
|
2018
Q3 | $19.3M | Sell |
1,165,846
-108,541
| -9% | -$1.84M | 0.01% | 1951 |
|
|
2018
Q2 | $21.3M | Buy |
1,274,387
+33,650
| +3% | +$545K | 0.01% | 1826 |
|
|
2018
Q1 | $19.3M | Buy |
1,240,737
+595,965
| +92% | +$10.6M | ﹤0.01% | 1887 |
|
|
2017
Q4 | $12.2M | Buy |
644,772
+57,709
| +10% | +$1.28M | ﹤0.01% | 2313 |
|
|
2017
Q3 | $17.1M | Buy |
587,063
+114,693
| +24% | +$3.39M | ﹤0.01% | 2125 |
|
|
2017
Q2 | $15.2M | Sell |
472,370
-131,591
| -22% | -$4.32M | ﹤0.01% | 2172 |
|
|
2017
Q1 | $20.9M | Buy |
603,961
+1,903
| +0.3% | +$68K | 0.01% | 1856 |
|
|
2016
Q4 | $21.2M | Sell |
602,058
-38,049
| -6% | -$1.29M | 0.01% | 1920 |
|
|
2016
Q3 | $22.2M | Buy |
640,107
+55,273
| +9% | +$1.93M | 0.01% | 1810 |
|
|
2016
Q2 | $21.9M | Sell |
584,834
-106,779
| -15% | -$4.01M | 0.01% | 1730 |
|
|
2016
Q1 | $28M | Buy |
691,613
+553,243
| +400% | +$20.6M | 0.01% | 1482 |
|
|
2015
Q4 | $4.98M | Buy |
138,370
+22,877
| +20% | +$828K | ﹤0.01% | 2832 |
|
|
2015
Q3 | $3.69M | Sell |
115,493
-16,427
| -12% | -$559K | ﹤0.01% | 3168 |
|
|
2015
Q2 | $4.49M | Sell |
131,920
-9,375
| -7% | -$316K | ﹤0.01% | 3059 |
|
|
2015
Q1 | $4.78M | Buy |
141,295
+56,778
| +67% | +$1.98M | ﹤0.01% | 2948 |
|
|
2014
Q4 | $2.97M | Sell |
84,517
-31,702
| -27% | -$1.07M | ﹤0.01% | 3461 |
|
|
2014
Q3 | $3.81M | Sell |
116,219
-36,229
| -24% | -$1.23M | ﹤0.01% | 3291 |
|
|
2014
Q2 | $5.18M | Sell |
152,448
-7,714
| -5% | -$264K | ﹤0.01% | 3002 |
|
|
2014
Q1 | $5.61M | Buy |
160,162
+4,390
| +3% | +$155K | ﹤0.01% | 2898 |
|
|
2013
Q4 | $5.7M | Sell |
155,772
-12,192
| -7% | -$447K | ﹤0.01% | 2939 |
|
|
2013
Q3 | $5.81M | Buy |
167,964
+55,385
| +49% | +$1.94M | ﹤0.01% | 2779 |
|
|
2013
Q2 | $3.81M | Buy |
+112,579
| New | +$3.74M | ﹤0.01% | 3024 |
|
Other funds holding ACH
CCM
ICM
PCMI
Goldman Sachs's ACH Position: Q2 2026 in Review
Goldman Sachs reduced its Accendra Health (ACH) stake by 9.2% in Q2 2026, selling an estimated $269K and leaving 854,730 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #4364.
Goldman Sachs first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $62M in Q4 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Goldman Sachs held 854,730 shares of Accendra Health worth $2.92M as of Q2 2026.
- Goldman Sachs sold 86,443 Accendra Health shares in Q2 2026, an estimated $269K.
- Accendra Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4364 holding.
- Goldman Sachs first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Accendra Health position peaked at $62M in Q4 2021.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.